Avient Valuation

Is AVNT undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

1/6

Valuation Score 1/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of AVNT when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: AVNT ($50.64) is trading below our estimate of fair value ($59.56)

Significantly Below Fair Value: AVNT is trading below fair value, but not by a significant amount.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for AVNT?

Key metric: As AVNT is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for AVNT. This is calculated by dividing AVNT's market cap by their current earnings.
What is AVNT's PE Ratio?
PE Ratio31.1x
EarningsUS$149.00m
Market CapUS$4.63b

Price to Earnings Ratio vs Peers

How does AVNT's PE Ratio compare to its peers?

The above table shows the PE ratio for AVNT vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average25.4x
ASH Ashland
18.9x5.0%US$3.8b
FUL H.B. Fuller
22.7x14.1%US$4.1b
NEU NewMarket
12.2xn/aUS$5.3b
BCPC Balchem
47.5x14.9%US$5.8b
AVNT Avient
31.1x20.4%US$4.6b

Price-To-Earnings vs Peers: AVNT is expensive based on its Price-To-Earnings Ratio (31.1x) compared to the peer average (25.4x).


Price to Earnings Ratio vs Industry

How does AVNT's PE Ratio compare vs other companies in the US Chemicals Industry?

7 CompaniesPrice / EarningsEstimated GrowthMarket Cap
FFHL Fuwei Films (Holdings)
2.8xn/aUS$27.11m
BSLK Bolt Projects Holdings
0.07xn/aUS$10.15m
BON Bon Natural Life
2.3xn/aUS$5.64m
GSPI Green Star Products
1.5xn/aUS$1.49m
AVNT 31.1xIndustry Avg. 23.6xNo. of Companies8PE01224364860+
7 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: AVNT is expensive based on its Price-To-Earnings Ratio (31.1x) compared to the US Chemicals industry average (23.6x).


Price to Earnings Ratio vs Fair Ratio

What is AVNT's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

AVNT PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio31.1x
Fair PE Ratio21x

Price-To-Earnings vs Fair Ratio: AVNT is expensive based on its Price-To-Earnings Ratio (31.1x) compared to the estimated Fair Price-To-Earnings Ratio (21x).


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst AVNT forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentUS$50.64
US$56.40
+11.4%
9.6%US$66.00US$51.00n/a5
Nov ’25US$46.14
US$56.40
+22.2%
9.6%US$66.00US$51.00n/a5
Oct ’25US$49.63
US$52.33
+5.4%
5.1%US$55.00US$47.00n/a6
Sep ’25US$49.13
US$52.33
+6.5%
5.1%US$55.00US$47.00n/a6
Aug ’25US$44.44
US$51.83
+16.6%
5.7%US$55.00US$47.00n/a6
Jul ’25US$42.18
US$51.83
+22.9%
5.7%US$55.00US$47.00n/a6
Jun ’25US$44.68
US$52.00
+16.4%
5.3%US$55.00US$47.00n/a7
May ’25US$42.98
US$46.71
+8.7%
7.9%US$50.00US$40.00n/a7
Apr ’25US$42.98
US$45.43
+5.7%
7.1%US$49.00US$40.00n/a7
Mar ’25US$40.53
US$45.43
+12.1%
7.1%US$49.00US$40.00n/a7
Feb ’25US$36.89
US$44.14
+19.7%
8.9%US$49.00US$37.00n/a7
Jan ’25US$41.57
US$44.14
+6.2%
8.9%US$49.00US$37.00n/a7
Dec ’24US$35.51
US$43.29
+21.9%
9.9%US$49.00US$37.00n/a7
Nov ’24US$31.45
US$47.14
+49.9%
7.1%US$50.00US$40.00US$46.147
Oct ’24US$35.32
US$47.43
+34.3%
7.4%US$50.00US$40.00US$49.637
Sep ’24US$40.48
US$47.43
+17.2%
7.4%US$50.00US$40.00US$49.137
Aug ’24US$40.80
US$47.43
+16.2%
7.4%US$50.00US$40.00US$44.447
Jul ’24US$40.90
US$46.71
+14.2%
8.5%US$52.00US$40.00US$42.187
Jun ’24US$36.76
US$47.00
+27.9%
8.0%US$52.00US$40.00US$44.688
May ’24US$38.76
US$47.63
+22.9%
7.3%US$52.00US$40.00US$42.988
Apr ’24US$41.16
US$47.63
+15.7%
7.3%US$52.00US$40.00US$42.988
Mar ’24US$43.86
US$47.67
+8.7%
6.9%US$52.00US$40.00US$40.539
Feb ’24US$41.15
US$41.75
+1.5%
13.0%US$50.00US$34.00US$36.898
Jan ’24US$33.76
US$40.75
+20.7%
15.1%US$50.00US$33.00US$41.578
Dec ’23US$35.16
US$38.50
+9.5%
17.5%US$50.00US$32.00US$35.518
Nov ’23US$34.99
US$45.25
+29.3%
18.0%US$61.00US$37.00US$31.458

Analyst Forecast: Target price is less than 20% higher than the current share price.


Discover undervalued companies